Marina Malikova, PhD
Assistant Professor
Boston University School of Medicine
Dept of Surgery

PhD, Russian Academy of Sciences
MA, Boston University School of Medicine
MSc, Voronezh State University




Dr. Malikova graduated from the Institute of Biochemistry, Russian Academy of Science, in Moscow, Russia with a PhD in Biochemistry. She has a strong background in biomedical sciences and has completed her postdoctoral fellowship in the field of cell signaling and cell migration. She also holds a Master’s Degree in Clinical Investigation and Project Management Certification from Boston University.

In her current role as Executive Director, Dr. Malikova manages research efforts in seven divisions of the Department of Surgery at Boston Medical Center. She is responsible for clinical trials and basic biomedical research operations, risk management, strategic planning, and macro-management of research programs. She provides guidance and oversight to the Project Managers, Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), and laboratory staff. She also provides assistance to investigators with protocol and informed consent writing, regulatory submissions, clinical trial agreements and budget development.

Executive Director
Boston University School of Medicine
Surgical Translational Research Operations and Compliance


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Malikova M., Webster P., Brahmbhatt T. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23, September 2022 Verona, Italy. Establishing Patient Safety Monitoring in the Benefit-Risk Paradigm for Off-Label and Emergency Use of Medications for COVID-19: A Pharmacovigilance Perspective. Drug Safety. Drug Safety. 2022; (45):1199–1200. View Publication
  2. Palin K., V. Kugener V., Salas M., Malikova M., Price J., Webster P., Cole A., Ely D., Habibi S., Joshi P. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Am2P: A New Accredited Academic Training Program in Pharmacovigilance and Pharmacoepidemiology Designed for US, Canadian and Caribbean Healthcare Professionals. Drug Safety. 2022; (45):1275–1276. View Publication
  3. Malikova M. and Kaliaev A. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Risk-Based Quality and Safety Management in Clinical Trials with Combination Devices in Changing Global Regulatory Environment. Drug Safety. Drug Safety. 2022; (45):1267. View Publication
  4. Cole A, Webster P, Van Liew D, Salas M, Aimer O, Malikova MA. Safety surveillance and challenges in accelerated COVID-19 vaccine development. Ther Adv Drug Saf. 2022; 13:20420986221116452. PMID: 36072284; PMCID: PMC9444812; DOI: 10.1177/20420986221116452;
     
  5. Li Y, He Y, Falzon I, Fairbourn B, Tingey S, Imrey PB, Radeva MK, Beck GJ, Gassman JJ, Roy-Chaudhury P, Berceli SA, Cheung AK, Shiu YT. Dynamic Remodeling of Human Arteriovenous Fistula Wall Obtained From Magnetic Resonance Imaging During the First 6 Months After Creation. Kidney Int Rep. 2022 Aug; 7(8):1905-1909. PMID: 35967120; PMCID: PMC9366358; DOI: 10.1016/j.ekir.2022.05.016;
     
  6. Malikova M, Jara H, Slanetz PJ. Evaluation of non-palpable breast lesions by quantitative magnetic resonance imaging in correlation with histopathology and radiological findings. 2022. View Publication
  7. Malikova MA. Biologics Development: A Regulatory Overview. Biosimilars. Barnette International Publishing Group. 2021.
  8. Malikova M.A. Impact of COVID-19 pandemic on conduct of clinical trials: lessons learned for risk and change management. International Journal of Clinical Trials. 2021; 8(1).
  9. Malikova MA. Practical applications of regulatory requirements for signal detection and communications in pharmacovigilance. Ther Adv Drug Saf. 2020; 11:2042098620909614. PMID: 32313617; PMCID: PMC7160767; DOI: 10.1177/2042098620909614;
     
  10. Kaliaev AO, Malikova MA. Risk-Based Quality and Compliance Management in Clinical Trials with Combination Products in Changing Global Regulatory Environment. Ther Innov Regul Sci. 2020 07; 54(4):803-813. PMID: 32557305
     
Showing 10 of 52 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 49 publications over 16 distinct years, with a maximum of 7 publications in 2018

YearPublications
20012
20021
20041
20071
20091
20102
20133
20142
20155
20164
20176
20187
20195
20201
20212
20226


2015 BU BEST Mentoring Circle: Valued Mentor Award
2005-2006 NIH: Travel Award
2001 International Union of Biochemistry and Molecular Biology: Travel Award
Contact for Mentoring:

88 E. Newton St Newton Pavilion
Boston MA 02118
Google Map

(617) 414-6835 (fax)

Malikova's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department